CIDRAP Daily headlines delivered to your inbox.
All 3 Zaire Ebola vaccine strategies in 4 African nations prompted an antibody response at 14 days that persisted for a year.
Of 58 tattoo parlor customers, 21 (36%) became infected with the virus, and 9 were children.
At least 5 European countries are reporting an increase in invasive group A Streptococcus disease and scarlet fever.
The monthly proportion of hospitalizations tied to psychological issues spiked after the emergence of COVID-19 in the US but not in France.
The study shows 32% of corpses in a Zambian morgue were positive for COVID-19, but only 10% of the individuals tested positive while alive.
Amid COVID-19 surges, people are scrambling to stockpile over-the-counter pain and fever medications.
The WHO says urgent action is needed if countries around the globe want to reach their water and sanitation goals.
The findings also call into question the idea that improving knowledge of antibiotics can improve antibiotic use, the study authors say.
The US, Canada, and Mexico confirm high flu levels, and 9 European countries are reporting widespread activity.
COVID-19 vaccines prevented more than 18.5 million US hospitalizations and 3.2 million deaths, according to new estimates.
Teens were more likely to receive COVID-19 vaccine if they had received HPV, meningitis, or Tdap vaccine.
The Taiwan Food and Drug Administration will review Shionogi's NDA for the novel antibiotic.
The outbreak has grown to more than 13,000 suspected cases, plus 283 deaths, for a case-fatality rate of 2.1%.
A new analysis identifies substantial inter-country differences, with variations by age, sex, and season.
A study of 4 VA hospitals finds that almost a third of urinary tract infection diagnoses are inappropriate in patients with neurogenic bladder.
No cases have been seen in children who are fully vaccinated.
CDC data show vaccine effectiveness against the H3N2 strain for all ages was 36%.
Slightly more than half of COVID-19–related scientific studies posted on medRxiv were published in peer-reviewed journals within 2 years.
Those who reported COVID-19 during wave 1 had elevated symptoms of anxiety and depression at 1, 3, 5, and 13 months follow-up.
Three men contracted mpox and then developed myocarditis a few days after their initial symptoms.
